文献速递肝病

原发性胆汁性胆管炎患者肠道微生物谱改变且经熊去氧胆酸治疗后部分恢复

Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy.
PubMed 文献 · Gut · 2017-02-17

该研究先在60例未接受熊去氧胆酸(UDCA)治疗的原发性胆汁性胆管炎(PBC)患者与80例匹配健康对照中开展横断面比较,另用19例未治疗患者和34例对照独立验证,并对37例患者UDCA治疗6个月前后的粪便行16S rRNA基因测序。PBC患者个体内微生物多样性显著降低(p=0.03),由4个属丰度降低和8个属丰度升高构成的菌群特征与PBC强相关(探索数据AUC=0.86,验证数据AUC=0.84),6个月UDCA治疗后6个PBC相关属的丰度发生逆转。

要点

  • PBC患者个体内肠道微生物多样性显著降低(p=0.03),并与健康对照存在明显菌群差异。
  • 由4个属丰度降低和8个属丰度升高构成的菌群特征与PBC强相关,探索与验证数据AUC分别为0.86和0.84。
  • UDCA治疗6个月后,6个PBC相关属的丰度发生逆转,提示菌群失调部分缓解。

核心结论

  • PBC患者存在肠道菌群失调,UDCA治疗可部分缓解;作者认为肠道微生物群是PBC的潜在治疗靶点和诊断生物标志物。

研究设计与样本

  • 横断面研究纳入60例未接受UDCA治疗的PBC患者和80例匹配健康对照,采用16S rRNA基因测序分析粪便微生物组。
  • 独立验证队列纳入19例未治疗患者和34例对照,用于验证菌群特征。
  • 前瞻性研究对37例PBC患者UDCA治疗前及治疗6个月后的粪便进行分析。

主要发现

  • PBC患者个体内微生物多样性显著降低(p=0.03)。
  • 由4个属丰度降低和8个属丰度升高构成的菌群特征与PBC强相关,探索数据AUC=0.86,验证数据AUC=0.84。
  • UDCA治疗6个月后,6个PBC相关属的丰度发生逆转。
  • 在对照组中富集的Faecalibacterium在gp210阳性患者中较gp210阴性患者进一步降低(p=0.002)。
  • PBC中推断的细菌侵袭上皮细胞通路能力增加,且与Enterobacteriaceae成员丰度高度相关。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: A close relationship between gut microbiota and some chronic liver disorders has recently been described. Herein, we systematically performed a comparative analysis of the gut microbiome in primary biliary cholangitis (PBC) and healthy controls. DESIGN: We first conducted a cross-sectional study of 60 ursodeoxycholic acid (UDCA) treatment-naïve patients with PBC and 80 matched healthy controls. Second, an independent cohort composed of 19 treatment-naïve patients and 34 controls was used to validate the results. Finally, a prospective study was performed in a subgroup of 37 patients with PBC who underwent analysis before and after 6 months of UDCA treatment. Faecal samples were collected, and microbiomes were analysed by 16S ribosomal RNA gene sequencing. RESULTS: A significant reduction of within-individual microbial diversity was noted in PBC (p=0.03). A signature defined by decreased abundance of four genera and increased abundance of eight genera strongly correlated with PBC (area under curve=0.86, 0.84 in exploration and validation data, respectively). Notably, the abundance of six PBC-associated genera was reversed after 6 months of UDCA treatment. In particular, Faecalibacterium, enriched in controls, was further decreased in gp210-positive than gp210-negative patients (p=0.002). Of interest was the finding that the increased capacity for the inferred pathway, bacterial invasion of epithelial cells in PBC, highly correlated with the abundance of bacteria belonging to Enterobacteriaceae. CONCLUSIONS: This study presents a comprehensive landscape of gut microbiota in PBC. Dysbiosis was found in the gut microbiome in PBC and partially relieved by UDCA. Our study suggests that gut microbiota is a potential therapeutic target and diagnostic biomarker for PBC.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Tang R, Wei Y, Li Y, et al. Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy. Gut. 2017. PMID: 28213609. doi:10.1136/gutjnl-2016-313332

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。